313 related articles for article (PubMed ID: 30277155)
1. Giardiasis: Characteristics, Pathogenesis and New Insights About Treatment.
Vivancos V; González-Alvarez I; Bermejo M; Gonzalez-Alvarez M
Curr Top Med Chem; 2018; 18(15):1287-1303. PubMed ID: 30277155
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidines: New leads for treatment of Giardia duodenalis infection.
Abraham RJ; Abraham S; Stevens AJ; Page SW; McCluskey A; Trott DJ; O'Handley RM
Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():38-44. PubMed ID: 31015151
[TBL] [Abstract][Full Text] [Related]
3. Giardiasis: a pharmacotherapy review.
Escobedo AA; Cimerman S
Expert Opin Pharmacother; 2007 Aug; 8(12):1885-902. PubMed ID: 17696791
[TBL] [Abstract][Full Text] [Related]
4. Giardia lamblia: a new target for miltefosine.
Eissa MM; Amer EI
Int J Parasitol; 2012 May; 42(5):443-52. PubMed ID: 22787585
[TBL] [Abstract][Full Text] [Related]
5. A novel in vitro image-based assay identifies new drug leads for giardiasis.
Hart CJ; Munro T; Andrews KT; Ryan JH; Riches AG; Skinner-Adams TS
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):83-89. PubMed ID: 28171818
[TBL] [Abstract][Full Text] [Related]
6. Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
Carter ER; Nabarro LE; Hedley L; Chiodini PL
Clin Microbiol Infect; 2018 Jan; 24(1):37-42. PubMed ID: 28624613
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel antigiardiasis drug candidates.
Kulakova L; Galkin A; Chen CZ; Southall N; Marugan JJ; Zheng W; Herzberg O
Antimicrob Agents Chemother; 2014 Dec; 58(12):7303-11. PubMed ID: 25267663
[TBL] [Abstract][Full Text] [Related]
8. Giardiasis: report of a case refractory to treatment.
Iza JA; Iza SN; Olivera MJ
Infez Med; 2019 Sep; 27(3):336-339. PubMed ID: 31545780
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of nitroimidazole-refractory giardiasis at the Hospital for Tropical Diseases, London: 2008-2013.
Nabarro LE; Lever RA; Armstrong M; Chiodini PL
Clin Microbiol Infect; 2015 Aug; 21(8):791-6. PubMed ID: 25975511
[TBL] [Abstract][Full Text] [Related]
10. Extra-intestinal and long term consequences of Giardia duodenalis infections.
Halliez MC; Buret AG
World J Gastroenterol; 2013 Dec; 19(47):8974-85. PubMed ID: 24379622
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a Giardia lamblia WB C6 clone resistant to the isoflavone formononetin.
Sterk M; Müller J; Hemphill A; Müller N
Microbiology (Reading); 2007 Dec; 153(Pt 12):4150-4158. PubMed ID: 18048928
[TBL] [Abstract][Full Text] [Related]
12. In vitro anti-Giardia lamblia activity of 2-aryl-3-hydroxymethyl imidazo[1,2-a]pyridines and -pyrimidines, individually and in combination with albendazole.
Velázquez-Olvera S; Salgado-Zamora H; Jiménez-Cardoso E; Campos-Aldrete ME; Pérez-González C; Ben Hadda T
Acta Trop; 2016 Mar; 155():6-10. PubMed ID: 26657313
[TBL] [Abstract][Full Text] [Related]
13. Aminosidine sulphate in experimental giardiasis.
Awadalla HN; el-Gowhary SH; Sadaka HA; Khalifa AM
J Egypt Soc Parasitol; 1995 Apr; 25(1):53-61. PubMed ID: 7602172
[TBL] [Abstract][Full Text] [Related]
14. Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia.
Kim WJ; Korthals KA; Li S; Le C; Kalisiak J; Sharpless KB; Fokin VV; Miyamoto Y; Eckmann L
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396548
[No Abstract] [Full Text] [Related]
15. 5-Nitroimidazole refractory giardiasis is common in Matanzas, Cuba and effectively treated by secnidazole plus high-dose mebendazole or quinacrine: a prospective observational cohort study.
Cañete R; Noda AL; Rodríguez M; Brito K; Herrera E; Kofoed PE; Ursing J
Clin Microbiol Infect; 2020 Aug; 26(8):1092.e1-1092.e6. PubMed ID: 31901492
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and electrochemistry of 2-ethenyl and 2-ethanyl derivatives of 5-nitroimidazole and antimicrobial activity against Giardia lamblia.
Valdez CA; Tripp JC; Miyamoto Y; Kalisiak J; Hruz P; Andersen YS; Brown SE; Kangas K; Arzu LV; Davids BJ; Gillin FD; Upcroft JA; Upcroft P; Fokin VV; Smith DK; Sharpless KB; Eckmann L
J Med Chem; 2009 Jul; 52(13):4038-53. PubMed ID: 19480409
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of 'Mexican Arnica' Heterotheca inuloides Cass natural products and some derivatives against Giardia intestinalis.
Rodríguez-Chávez JL; Rufino-González Y; Ponce-Macotela M; Delgado G
Parasitology; 2015 Apr; 142(4):576-84. PubMed ID: 25363565
[TBL] [Abstract][Full Text] [Related]
18. Multilevel Approach for the Treatment of Giardiasis by Targeting Arginine Deiminase.
Fernández-Lainez C; de la Mora-de la Mora I; García-Torres I; Enríquez-Flores S; Flores-López LA; Gutiérrez-Castrellón P; Yépez-Mulia L; Matadamas-Martínez F; de Vos P; López-Velázquez G
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502400
[TBL] [Abstract][Full Text] [Related]
19. Activity of Thioallyl Compounds From Garlic Against
Argüello-García R; de la Vega-Arnaud M; Loredo-Rodríguez IJ; Mejía-Corona AM; Melgarejo-Trejo E; Espinoza-Contreras EA; Fonseca-Liñán R; González-Robles A; Pérez-Hernández N; Ortega-Pierres MG
Front Cell Infect Microbiol; 2018; 8():353. PubMed ID: 30374433
[TBL] [Abstract][Full Text] [Related]
20. Treatment of patients with refractory giardiasis.
Nash TE; Ohl CA; Thomas E; Subramanian G; Keiser P; Moore TA
Clin Infect Dis; 2001 Jul; 33(1):22-8. PubMed ID: 11389490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
